The Importance of the Role
This leadership role will develop and execute translational, clinical pharmacology, and pharmacometrics strategies and deliverables from early through late-stage clinical development. Manage a team of scientists and serve as a SME on programs.
Responsibilities
- Lead clinical pharmacology and pharmacometrics workstreams in CNS diseases (rare disease drug development experience preferred)
- Serve as therapeutic lead (siRNA/oligonucleotide experience preferred) and SME for clinical pharmacology strategies, protocol preparation, study execution, data review/analysis, and study reports
- Lead translational, mechanistically based PK/PD modeling to enable FIH dose selection and early efficacy/safety characterization using biomarkers and disease animal models
- Lead pharmacometrics strategies across all stages (population PK, PK/PD modeling and simulations, meta-analysis, disease modeling)
- Support non-clinical PK/PD, ADME, and DMPK evaluations (strategy, study design/execution, analyses to inform lead optimization and candidate selection)
- Lead global regulatory activities and Health Authority engagements (NDA and/or BLA experience required)
- Supervise, mentor, and develop scientists
- Contribute to platform-based pharmacology activities across genetic modalities and disease indications
- Publish manuscripts and advocate scientific leadership at external conferences
Qualifications
- PhD in Clinical Pharmacology, Pharmacometrics, Pharmaceutical Sciences, or related field with β₯10 years biotech/pharma experience
- Expertise in clinical pharmacology/pharmacometrics; hands-on modeling and data analytics; regulatory success from IND through registration
- siRNA and/or oligonucleotide experience highly preferred
- Proven success leading high-performing teams and developing people
- Excellent communication, multitasking, and collaboration in cross-functional/matrixed environments
Application/Work Details
- Hybrid role; work on-site in the U.S. and/or attend in-person events from time to time.